Walder Wyss advised UBS Switzerland AG in the operation. UBS Switzerland AG operate as sole mandated lead arranger, sole bookrunner, agent and lender, with a syndicate of...
UBS Switzerland AG’s €1.4 Billion Mutlicurrency Syndacated Revolving Credit Facility
Investcorp’s Investment in Terra Quantum
Walder Wyss and HEUSSEN Rechtsanwaltsgesellschaft mbH advised Terra Quantum AG on the deal. Terra Quantum AG announced the onboarding of Investcorp as its newest investor. Quantum has...
Distalmotion’s $150 Million Series F Financing Round
Walder Wyss advised Distalmotion in connection with the transaction. Distalmotion SA successfully closed the first tranche of its $150 million Series F financing round led by...
ITS Kanal Services’ Acquisition of Künzli Group
Walder Wyss advised ITS Kanal Services Ltd on the deal. ITS Kanal Services Ltd acquired Künzli Group. Künzli Group is active in the areas of wastewater...
Alentis Therapeutics’ $105 Million Series C Funding Round
Walder Wyss advises Alentis Therapeutics on the financing. Alentis Therapeutics has announced $105 million in Series C financing. The funding round was led by Jeito Capital...
ImmunoGen’s $175 Million Term Loan Financing
Ropes & Gray advised ImmunoGen, while Walder Wyss advised the funds managed by Pharmakon Advisors. ImmunoGen, Inc. (Nasdaq: IMGN) announced it has entered into a term loan...
Collana IT’s Acquisition of PENTAG Informatik
Walder Wyss advised collana IT on the transaction. collana IT GmbH has acquired PENTAG Informatik AG, a Swiss IT service provider based in Ittingen (Bern). PENTAG...
PwC Switzerland’s Acquisition of Avoras
Walder Wyss has advised the Avoras in this transaction. As part of its growth strategy, PwC Switzerland acquires Avoras, an established SAP-based business transformation consultant in...
Hôpital de La Tour à Meyrin’s Sale and Lease Agreement
Walder Wyss acted as counsel to UBP and RMG on all aspects of this transaction. A consortium of investors, advised by Union Bancaire Privée, UBP SA (UBP)...
Axiom Group’s Acquisition of Swisslinx
Walder Wyss advised the sellers and Swisslinx on this transaction. Axiom group, an established investor with a focus on high-growth companies, acquired Swisslinx International Ltd. and...
Fundamenta Group’s Acquisition of Belvédère Asset Management
Walder Wyss has advised Fundamenta Group on the deal. Fundamenta Group Holding AG acquired 100% of the shares of Belvédère Asset Management AG. In return, the previous...
Bavarian Nordic’s $380 Million Acquisition of Emergent BioSolutions’ Travel Vaccines Portfolio
Walder Wyss AG acted as Swiss counsel to Bavarian Nordic. Bavarian Nordic, a vaccine company, has entered into a definitive agreement to acquire Emergent BioSolutions’ travel...